Peptides

Peptides

 

 

Glatiramer Acetate,147245-92-9
Glatiramer acetate,147245-92-9
Product Name
Glatiramer Acetate
Synonyms
Copolymer 1 
Systematic Name
L-Glutamic acid polymer with L-alanine, L-lysine and L-tyrosine, acetate (salt)
CAS No.
147245-92-9
Molecular Formula 
N/A
Molecular Weight
623.6525 
Packing
1g
Assay
9.8%
COA
Specification
Appearance
A white to slightly yellowish lyophilizd solid.
Complies
Identification
IR:1640 -1660;1530-1570;1380-1420
Complies
UVmax:270-280nm;215-225nm;195-210nm
Complies
Solubility
Soluble in water and acetic acid,insoluble in acetone
Complies
Residue on Ignition
N.M.T:0.1%
Complies
Water
N.M.T:15.0%
5.8%
Heavy metal
N.M.T:20ppm
2ppm
Amino acid analysis
L-alanine:3.50-5.50
3.8
L-glutamie acid:1.2-1.8
1.5
L-lysine:2.5-4.5
3.0
L-tyrosine:0.8-1.2
1.0
MW 2.0K-40KDa
N.L.T:50%
71.3%
Average Molecular
4.5-11KDa
8.0
Weight distribution acetate content
9.5% - 12.0%
9.8%
Contact us for more information
Chemical information
Compound Name*
CAS No. "N/A" if the CAS not available*
Quantity*
Contact information
Contact person*
Email Address *
Tel No.*
Company or Organization Name*
Shipping Address*
Country
Remarks

<Privacy policy: the contact information will be only used for this business contact>

Related Peptides
Patent Disclaimer
PD1
Products protected by valid patents are not offered for sale in jurisdictions where the sale of such products constitutes a patent infringement. The current list only reflects the products and technologies that are available, under development: note that some products may be developed or produced for internal and experimental uses with no commercal aim.
PD2
Sales of products are limited to those allowed by Chapter VII PLPRC 63, the above includes Research and development quantities.
PD3
the buyer assumes responsibility of all patent considerations in the use of
Lano ’s Pharmaceutical Co.,Ltd product(Glatiramer Acetate,147245-92-9).
PD4
R&D use in accordance with (1) 35 USC 271(e)+A13(1) in the U.S.; (2) Section 69.1 of Japanese Patent Law in Japan; (3) Section 11, No. 2 of the German Patent Act of 1981 in Germany; (iv) Section 60, Paragraph 5b of the U.K. Patents Act of 1977 in the U.K.; (4) Sections 55.2(1) and 55.2(6) and other common law exemptions of Canadian patent law; (5) Section 68B of the Patents Act of 1953 in New Zealand together with the amendment of same by the Statutes Amendment Bill of 2002; (6) such related legislation and/or case law as may be or become applicable in the aforementioned countries; and (7) such similar laws and rules as may apply in various other countries.